BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36800747)

  • 21. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.
    Danassegarane G; Tinois J; Sahler Y; Aouaissia S; Riffaud L
    Neurochirurgie; 2022 Dec; 68(6):627-636. PubMed ID: 35907444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
    Kingswood JC; Jozwiak S; Belousova ED; Frost MD; Kuperman RA; Bebin EM; Korf BR; Flamini JR; Kohrman MH; Sparagana SP; Wu JY; Brechenmacher T; Stein K; Berkowitz N; Bissler JJ; Franz DN
    Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
    Giordano F; Moscheo C; Lenge M; Biagiotti R; Mari F; Sardi I; Buccoliero AM; Mongardi L; Aronica E; Guerrini R; Genitori L
    Childs Nerv Syst; 2020 May; 36(5):951-960. PubMed ID: 31853898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
    Mateos-González ME; López-Laso E; Vicente-Rueda J; Camino-León R; Fernández-Ramos JA; Baena-Gómez MA; Peña-Rosa MJ
    Rev Neurol; 2014 Dec; 59(11):497-502. PubMed ID: 25418144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
    Cheng S; Hawkins C; Taylor MD; Bartels U
    Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort study.
    Sun P; Liu Z; Krueger D; Kohrman M
    J Med Econ; 2015 May; 18(5):349-56. PubMed ID: 25525770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the management of subependymal giant cell astrocytoma.
    Beaumont TL; Limbrick DD; Smyth MD
    Childs Nerv Syst; 2012 Jul; 28(7):963-8. PubMed ID: 22562196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: Case report.
    Konakondla S; Jayarao M; Skrade J; Giannini C; Workman MJ; Morgan CJ
    Clin Neurol Neurosurg; 2016 Nov; 150():177-180. PubMed ID: 27690251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser interstitial thermal therapy compared with open resection for treating subependymal giant cell astrocytoma.
    Aum DJ; Reynolds RA; McEvoy SD; Wong M; Roland JL; Smyth MD
    J Neurosurg Pediatr; 2024 Jan; 33(1):95-104. PubMed ID: 37922551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
    Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.
    Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Berkowitz N; Anak O; Niolat J; Jozwiak S
    Lancet Oncol; 2014 Dec; 15(13):1513-1520. PubMed ID: 25456370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subependymal Giant Cell Astrocytoma Tumors in Patients Without Clinical Manifestation of Tuberous Sclerosis Complex: A Diagnostic Puzzle.
    Zabielska B; Rzewuska N; Jóźwiak S
    Pediatr Neurol; 2023 Sep; 146():116-118. PubMed ID: 37478630
    [No Abstract]   [Full Text] [Related]  

  • 33. Subependymal Giant Cell Astrocytoma Tumors in Patients Without Clinical Manifestation of Tuberous Sclerosis Complex: A Diagnostic Puzzle.
    Zabielska B; Rzewuska N; Jóźwiak S
    Pediatr Neurol; 2024 Jan; 150():40-42. PubMed ID: 37951161
    [No Abstract]   [Full Text] [Related]  

  • 34. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Fogarasi A; De Waele L; Bartalini G; Jozwiak S; Laforgia N; Verhelst H; Petrak B; Pedespan JM; Witt O; Castellana R; Crippa S; Gislimberti G; Gyorsok Z
    BMC Neurol; 2016 Aug; 16():126. PubMed ID: 27502586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.
    Kuzniewska B; Sadowski K; Urbanska K; Urbanska M; Kotulska K; Liszewska E; Grajkowska W; Jóźwiak S; Dziembowska M
    Folia Neuropathol; 2018; 56(3):167-174. PubMed ID: 30509037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
    J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.
    Jansen AC; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC
    Front Neurol; 2019; 10():705. PubMed ID: 31333563
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.
    Jóźwiak S; Mandera M; Młynarski W
    Semin Pediatr Neurol; 2015 Dec; 22(4):274-81. PubMed ID: 26706014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
    Tsai JD; Wei CC; Tsao TF; Hsiao YP; Tsai HJ; Yang SH; Tsai ML; Sheu JN
    Childs Nerv Syst; 2016 Jan; 32(1):89-95. PubMed ID: 26552385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.
    Kotulska K; Borkowska J; Mandera M; Roszkowski M; Jurkiewicz E; Grajkowska W; Bilska M; Jóźwiak S
    Childs Nerv Syst; 2014 Dec; 30(12):2037-42. PubMed ID: 25227171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.